Cerulean Pharma reported $-12667000 in Net Income for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Agile Therapeutics AGRX:US $ -16.77M 0.86M
Arrowhead Research ARWR:US $ -63374000 33.45M
Bayer BAYN:GR € 85M 2420M
Biocept BIOC:US $ 0.43M 2.26M
Brainstorm Cell Therapeutics BCLI:US $ -5.34M 0.93M
Cerulean Pharma CERU:US $ -12.67M 3.5M
Immunogen IMGN:US $ -37.34M 6.6M
Johnson & Johnson JNJ:US $ 3667M 2611M
Macrogenics MGNX:US $ -52.89M 12.95M
Merk MRK:US $ 4567M 3022M
Nektar Therapeutics NKTR:US $ -129.71M 4.19M
Perrigo Ordinary Shares PRGO:US $ -58.9M 1.2M
Pfizer PFE:US $ 8146M 2582M
Seattle Genetics SGEN:US $ -293.85M 209.27M
YTE INCY:US $ 181.74M 32.28M